DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
16,420
-110 (-0.67%)
Jan 19, 2026, 3:30 PM KST
DongKook Pharmaceutical Market Cap
DongKook Pharmaceutical has a market cap or net worth of 734.61 billion as of January 16, 2026. Its market cap has increased by 0.41% in one year.
Market Cap
734.61B
Enterprise Value
790.42B
Revenue
894.93B
Ranking
n/a
PE Ratio
12.08
Stock Price
16,420.00
Market Cap Chart
Since May 29, 2007, DongKook Pharmaceutical's market cap has increased from 161.32B to 734.61B, an increase of 355.37%. That is a compound annual growth rate of 8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 739.53B | -3.62% |
| Dec 30, 2025 | 767.27B | 5.63% |
| Dec 30, 2024 | 726.36B | 2.24% |
| Dec 28, 2023 | 710.43B | -2.64% |
| Dec 29, 2022 | 729.66B | -23.84% |
| Dec 30, 2021 | 958.07B | -25.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |